Kentaro Yamato

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Cross Sectional

Prognostic Factors

Cardiac Surgery

Ejection Fraction

Top Venues

PharmacoEconomics

Drugs - real world outcomes

Cancer medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Takao Takeshima, Fumihiko Sakai, Xinyu Wang, Kentaro Yamato, Yoshitsugu Kojima, Yilong Zhang, Craig Bennison, Martijn J H G Simons
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective. PharmacoEconomics (2024)
Takao Takeshima, Fumihiko Sakai, Xinyu Wang, Kentaro Yamato, Yoshitsugu Kojima, Yilong Zhang, Craig Bennison, Martijn J H G Simons
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective. PharmacoEconomics 42 (7) (2024)
Takao Takeshima, Fumihiko Sakai, Xinyu Wang, Kentaro Yamato, Yoshitsugu Kojima, Yilong Zhang, Craig Bennison, Martijn J H G Simons
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective. PharmacoEconomics 42 (7) (2024)
Takao Takeshima, Fumihiko Sakai, Xinyu Wang, Kentaro Yamato, Yoshitsugu Kojima, Yilong Zhang, Craig Bennison, Martijn J H G Simons
Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective. PharmacoEconomics 42 (7) (2024)
Kentaro Yamato, Ai Ikeda, Motoki Endo, Ronald Filomeno, Kosuke Kiyohara, Ken Inada, Katsuji Nishimura, Takeshi Tanigawa
An association between cancer type and delirium incidence in Japanese elderly patients: A retrospective longitudinal study. Cancer medicine (2022)
Ken Inada, Minori Enomoto, Kentaro Yamato, Kazuo Mishima
Prescribing Pattern of Hypnotic Medications in Patients Initiating Treatment at Japanese Hospitals: A Nationwide, Retrospective, Longitudinal, Observational Study Using a Claims Database. Drugs - real world outcomes 8 (3) (2021)